Abstract:BACKGROUND:Diabetes mellitus (DM) increases the risk of adverse maternal and neonatal outcomes, and optimization of glycemic control during pregnancy can help mitigate risks associated with diabetes. However, studies seldom focus precisely on maternal blood glucose level prior to pregnancy. We aimed to evaluate the associations between preconception blood fasting plasma glucose (FPG) level and subsequent pregnancy outcomes.METHODS AND FINDINGS:We conducted a population-based retrospective cohort study among 6,447,339 women aged 20-49 years old who participated in National Free Pre-Pregnancy Checkups Project and completed pregnancy outcomes follow-up between 2010 and 2016 in China. During the preconception health examination, serum FPG concentration was measured, and self-reported history of DM was collected. Women were classified into three groups (normal FPG group: FPG < 5.6 mmol/L and no self-reported history of DM; impaired fasting glucose [IFG]: FPG 5.6-6.9 mmol/L and no self-reported history of DM; and DM: FPG ≥ 7.0 mmol/L or self-reported history of DM). The primary outcomes were adverse pregnancy outcomes, including spontaneous abortion, preterm birth (PTB), macrosomia, small for gestational age infant (SGA), birth defect, and perinatal infant death. Logistic regression model was used to calculate odds ratio (OR) and 95% confidence interval (CI) after adjusting for confounding variables. The mean age of women was 25.24 years, 91.47% were of Han nationality, and 92.85% were from rural areas. The incidence of DM and IFG was 1.18% (76,297) and 13.15% (847,737), respectively. Only 917 (1.20%) women reported a history of DM (awareness of their DM status), of whom 37.28% (337) had an elevated preconception FPG level (≥ 5.6 mmol/L), regarded as noncontrolled DM. A total of 1,005,568 (15.60%) women had adverse pregnancy outcomes. Compared with women with normal FPG, women with IFG had higher risks of spontaneous abortion (OR 1.08; 95% CI 1.06-1.09; P < 0.001), PTB (1.02; 1.01-1.03; P < 0.001), macrosomia (1.07; 1.06-1.08; P < 0.001), SGA (1.06; 1.02-1.10; P = 0.007), and perinatal infant death (1.08; 1.03-1.12; P < 0.001); the corresponding ORs for women with DM were 1.11 (95% CI 1.07-1.15; P < 0.001), 1.17 (1.14-1.20; P < 0.001), 1.13 (1.09-1.16; P < 0.001), 1.17 (1.04-1.32; P = 0.008), and 1.59 (1.44-1.76; P < 0.001). Women with DM also had a higher risk of birth defect (OR 1.42; 95% CI 1.15-1.91; P = 0.002). Among women without self-reported history of DM, there was a positive linear association between FPG levels and spontaneous abortion, PTB, macrosomia, SGA, and perinatal infant death (P for trend <0.001, <0.001, <0.001, 0.001, <0.001). Information about hypoglycemic medication before or during pregnancy was not collected, and we cannot adjust it in the analysis, which could result in underestimation of risks. Data on 2-hour plasma glucose level and HbA1c concentration were not available, and the glycemic control status was evaluated according to FPG value in women with DM.CONCLUSIONS:Women with preconception IFG or DM had higher risk of adverse pregnancy outcomes, including spontaneous abortion, PTB, macrosomia, SGA, and perinatal infant death. Preconception glycemic control through appropriate methods is one of the most important aspects of preconception care and should not be ignored by policy makers.

Gestational diabetes mellitus and risk of long-term all-cause and cardiac mortality: a prospective cohort study

The Association of Gestational Diabetes Mellitus with Fetal Birth Weight.

Preconception Diabetes Mellitus and Adverse Pregnancy Outcomes in over 6.4 Million Women: A Population-Based Cohort Study in China

Association of Gestational Diabetes With Subsequent Long-Term Risk of Mortality

Association of gestational diabetes with long‐term risk of premature mortality, and cardiovascular outcomes and risk factors: A retrospective cohort analysis in the UK Biobank

Gestational diabetes mellitus, body mass index, and cardiometabolic multimorbidity: A prospective cohort study

Association Between Gestational Diabetes Mellitus and the Risks of Type-Specific Cardiovascular Diseases

Association between lipid trajectories during pregnancy and risk of postpartum glucose intolerance after gestational diabetes mellitus: a cohort study

Association of gestational diabetes mellitus with adverse pregnancy outcomes: our experience and meta-analysis

Association between cardiometabolic index and gestational diabetes mellitus: a cross-sectional study

Association of Gestational Diabetes With Subclinical Cardiovascular Disease

Long-term Outcome of Postpartum Glucose Metabolism in Patients with Gestational Diabetes Mellitus

Updates in Long-term Maternal and Fetal Adverse Effects of Gestational Diabetes Mellitus

Combined healthy lifestyle in early pregnancy and risk of gestational diabetes mellitus: A prospective cohort study

Gestational hyperglycemia and the risk of cardiovascular diseases among elderly Chinese women: Findings from the REACTION study

Gestational Diabetes Mellitus and Renal Function: A Prospective Study With 9- to 16-Year Follow-up After Pregnancy

Effect of Dietary and Lifestyle Factors on the Risk of Gestational Diabetes: Review of Epidemiologic Evidence.

Prevalence and Determinants of Gestational Diabetes Mellitus: A Cross-Sectional Study in China

Gestational Diabetes with Diabetes and Prediabetes Risks: a Large Observational Study.

Gestational Diabetes Mellitus As an Effect Modifier of the Association of Gestational Weight Gain with Perinatal Outcomes: A Prospective Cohort Study in China

Modifiable Risk Factors and Long-term Risk of Type 2 Diabetes among Individuals with a History of Gestational Diabetes Mellitus: Prospective Cohort Study